GM23814
Fibroblast from Skin, Unspecified
Description:
LESCH-NYHAN SYNDROME; LNS
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
4.34 |
Passage Frozen |
2 |
|
hypoxanthine phosphoribosyltransferase |
According to the submitter biochemical test results for this subject showed decreased enzyme activity.
EC Number: 2.4.2.8; 20% activity. |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
HPRT1 |
Chromosomal Location |
Xq26-q27.2 |
Allelic Variant 1 |
308000.0060; LESCH-NYHAN SYNDROME, NEUROLOGIC VARIANT |
Identified Mutation |
ARG48HIS |
Remarks |
Clinically affected; variant; onset of symptoms in first year of life; mild dystonia; hyperreflexia; clonus; IQ = 96; onychophagia; residual HGPRT enzyme activity is 20% in cultured fibroblasts; no assistive devices used; donor subject is hemizygous for a G>A transition at nucleotide 143 in exon 3 of the HPRT1 gene (143G>A) resulting in the substitution of histidine for arginine at codon 48 [Arg48His (R48H)]. |
Jinnah HA, Ceballos-Picot I, Torres RJ, Visser JE, Schretlen DJ, Verdu A, LarĂ³vere LE, Chen CJ, Cossu A, Wu CH, Sampat R, Chang SJ, de Kremer RD, Nyhan W, Harris JC, Reich SG, Puig JG, Lesch-Nyhan Disease International Study Group JG, Attenuated variants of Lesch-Nyhan disease Brain : a journal of neurology133:671-89 2010 |
PubMed ID: 20176575 |
|
Sampat R, Fu R, Larovere LE, Torres RJ, Ceballos-Picot I, Fischbach M, de Kremer R, Schretlen DJ, Puig JG, Jinnah HA, Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants Human genetics129:71-8 2010 |
PubMed ID: 20981450 |
Cumulative PDL at Freeze |
4.34 |
Passage Frozen |
2 |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Supplement |
- |
|
|